Worth reading
69In focus
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
8462000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Monthly exercise status of the 39th Stock Acquisition Rights issued through a third-party allotment (with Exercise Price Adjustment Clause)
Who receives how much
Number of shares delivered during the month: 8,462,000 shares (8,462,000 new shares and 0 treasury shares transferred)
EVO FUND (84,620 rights exercised; allottee at issuance)
The lower thin line represents the existing number of shares to which these shares will be added.
発行済株式総数
Exercise ratio subject to the exercise restriction: 10.0% (the actual ratio was below 10.0%)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
The exercise price during July 2026 was ¥21.0, ¥22.0 or ¥23.0. Details of the adjustment clause and the floor: Not disclosed
Number of Stock Acquisition Rights
Total number issued: 600,000 rights; exercised during the subject month: 84,620 rights; unexercised at the end of the preceding month: 515,370 rights; unexercised at the end of the subject month: 430,750 rights
Procedures under the Corporate Code of Conduct
The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations
Most recent equity financing
Issued on 1 June 2026: 39th Stock Acquisition Rights (with an exercise price adjustment clause), allotted to EVO FUND
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly exercise status of the 39th Stock Acquisition Rights issued through a third-party allotment (with Exercise Price Adjustment Clause) |
| Number of shares to be issued or disposed of | Number of shares delivered during the month: 8,462,000 shares (8,462,000 new shares and 0 treasury shares transferred) |
| Intended allottee | EVO FUND (84,620 rights exercised; allottee at issuance) |
| Dilution Rate | Exercise ratio subject to the exercise restriction: 10.0% (the actual ratio was below 10.0%) |
| Total number of issued shares | 93,101,408 shares (as of the end of the month preceding the subject month, including 101 treasury shares) → Not disclosed |
| Exercise price | The exercise price during July 2026 was ¥21.0, ¥22.0 or ¥23.0. Details of the adjustment clause and the floor: Not disclosed |
| Number of Stock Acquisition Rights | Total number issued: 600,000 rights; exercised during the subject month: 84,620 rights; unexercised at the end of the preceding month: 515,370 rights; unexercised at the end of the subject month: 430,750 rights |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations |
| Most recent equity financing | Issued on 1 June 2026: 39th Stock Acquisition Rights (with an exercise price adjustment clause), allotted to EVO FUND |
Items this document does not state (19)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status for July 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.